Canopy Growth Corp vs iShares MSCI Malaysia ETF — how do they compare? Canopy Growth Corp trades at $0.97 (market cap $398.46M), while iShares MSCI Malaysia ETF trades at $28.03. The key difference: iShares MSCI Malaysia ETF is trading nearer its 52-week high, Canopy Growth Corp nearer its low. Which is the better fit depends on your goals.
| CGC | EWM | |
|---|---|---|
Market Cap | $398.46M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $1.92 | $30.42 |
52-Week Low | $0.86 | $23.49 |
Enterprise Value | $337.90M | — |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
EWM (iShares MSCI Malaysia ETF) trades at $27.50, up 0.26% with a bullish technical signal despite mixed moving averages. The ETF offers concentrated exposure to Malaysia's financial (54%) and industrial (21%) sectors, benefiting from data center expansion and tourism initiatives. RSI levels show potential overbought conditions near-term, while ADX indicates strong trend momentum. Support and resistance cluster around $27-$28 levels.
Outlook remains cautiously optimistic given Malaysia's economic initiatives, though concentrated sector exposure and regional geopolitical risks warrant monitoring. The dividend scheduled for June 2026 provides income appeal, while technical indicators suggest potential consolidation near current levels before further directional moves.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →EWM tracks the MSCI Malaysia Index, providing exposure to the Malaysian equity market. It offers a diversified portfolio of large and mid-sized companies across various sectors in Malaysia.
Read more on EWM →